220 related articles for article (PubMed ID: 3016984)
1. Point mutations in the U3 region of the long terminal repeat of Moloney murine leukemia virus determine disease specificity of the myeloproliferative sarcoma virus.
Stocking C; Kollek R; Bergholz U; Ostertag W
Virology; 1986 Aug; 153(1):145-9. PubMed ID: 3016984
[TBL] [Abstract][Full Text] [Related]
2. Comparison of myeloproliferative sarcoma virus with Moloney murine sarcoma virus variants by nucleotide sequencing and heteroduplex analysis.
Stacey A; Arbuthnott C; Kollek R; Coggins L; Ostertag W
J Virol; 1984 Jun; 50(3):725-32. PubMed ID: 6328002
[TBL] [Abstract][Full Text] [Related]
3. Study of the 78A1 isolate of Moloney murine sarcoma virus. II. Haematopoietic tropism and tumourigenicity.
Le Bousse-Kerdiles MC; Dumenil D; Smadja-Joffe F; Bertoli AM; Degiorgis V; Auger-Buendia MA; Tavitian A; Jasmin C
J Gen Virol; 1985 Nov; 66 ( Pt 11)():2415-21. PubMed ID: 2997375
[TBL] [Abstract][Full Text] [Related]
4. Long terminal repeat sequences impart hematopoietic transformation properties to the myeloproliferative sarcoma virus.
Stocking C; Kollek R; Bergholz U; Ostertag W
Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5746-50. PubMed ID: 2994046
[TBL] [Abstract][Full Text] [Related]
5. Viral transfer, transcription, and rescue of a selectable myeloproliferative sarcoma virus in embryonal cell lines: expression of the mos oncogene.
Seliger B; Kollek R; Stocking C; Franz T; Ostertag W
Mol Cell Biol; 1986 Jan; 6(1):286-93. PubMed ID: 3023829
[TBL] [Abstract][Full Text] [Related]
6. Rates of evolution of the retroviral oncogene of Moloney murine sarcoma virus and of its cellular homologues.
Gojobori T; Yokoyama S
Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4198-201. PubMed ID: 2987967
[TBL] [Abstract][Full Text] [Related]
7. Retroviral mutants efficiently expressed in embryonal carcinoma cells.
Franz T; Hilberg F; Seliger B; Stocking C; Ostertag W
Proc Natl Acad Sci U S A; 1986 May; 83(10):3292-6. PubMed ID: 3010288
[TBL] [Abstract][Full Text] [Related]
8. v-mos proteins encoded by myeloproliferative sarcoma virus and its ts159 mutant.
Singh B; Stocking C; Walker R; Yang YD; Ostertag W; Arlinghaus RB
J Virol; 1992 Feb; 66(2):1267-72. PubMed ID: 1309903
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning and characterization of a leukemia-inducing myeloproliferative sarcoma virus and two of its temperature-sensitive mutants.
Kollek R; Stocking C; Smadja-Joffe F; Ostertag W
J Virol; 1984 Jun; 50(3):717-24. PubMed ID: 6328001
[TBL] [Abstract][Full Text] [Related]
10. Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties.
Hanecak R; Pattengale PK; Fan H
J Virol; 1988 Jul; 62(7):2427-36. PubMed ID: 2836623
[TBL] [Abstract][Full Text] [Related]
11. Study of the 78A1 isolate of Moloney murine sarcoma virus. I. Molecular cloning and characterization.
Devaux J; Jouanneau J; Quibriac M; Longuet M; Le Bousse-Kerdiles MC; Auger-Buendia MA; Tavitian A
J Gen Virol; 1985 Nov; 66 ( Pt 11)():2407-14. PubMed ID: 2997374
[TBL] [Abstract][Full Text] [Related]
12. Rearrangements and insertions in the Moloney murine leukemia virus long terminal repeat alter biological properties in vivo and in vitro.
Fan H; Mittal S; Chute H; Chao E; Pattengale PK
J Virol; 1986 Oct; 60(1):204-14. PubMed ID: 3747027
[TBL] [Abstract][Full Text] [Related]
13. The myeloproliferative sarcoma virus retains transforming functions after introduction of a dominant selectable marker gene.
Ostertag W; Seliger B; Kollek R; Stocking C; Bergholz U; Smadja-Joffe F
J Gen Virol; 1986 Jul; 67 ( Pt 7)():1361-71. PubMed ID: 3014049
[TBL] [Abstract][Full Text] [Related]
14. Escape from in vivo restriction of Moloney mink cell focus-inducing viruses driven by the Mo+PyF101 long terminal repeat (LTR) by LTR alterations.
Brightman BK; Farmer C; Fan H
J Virol; 1993 Dec; 67(12):7140-8. PubMed ID: 8230436
[TBL] [Abstract][Full Text] [Related]
15. Abrogation of the requirement for feeder cell interaction and T cell receptor stimulation of lymphocytes infected with retroviral vectors.
Laker C; Gräning G; Kelso A; Stocking C; Ostertag W
J Exp Med; 1990 Aug; 172(2):447-56. PubMed ID: 2165126
[TBL] [Abstract][Full Text] [Related]
16. Stable expression of a selectable myeloproliferative sarcoma virus in murine T lymphocyte and monocyte cell lines.
Seliger B; Kruppa G; Pfizenmaier K
Immunobiology; 1987 May; 174(3):313-25. PubMed ID: 3040583
[TBL] [Abstract][Full Text] [Related]
17. A DNA element responsible for the different tissue specificities of Friend and Moloney retroviral enhancers.
Thiesen HJ; Bösze Z; Henry L; Charnay P
J Virol; 1988 Feb; 62(2):614-8. PubMed ID: 2826819
[TBL] [Abstract][Full Text] [Related]
18. Substitution of murine transthyretin (prealbumin) regulatory sequences into the Moloney murine leukemia virus long terminal repeat yields infectious virus with altered biological properties.
Feuer G; Fan H
J Virol; 1990 Dec; 64(12):6130-40. PubMed ID: 2173784
[TBL] [Abstract][Full Text] [Related]
19. Role for the 3' end of the genome in determining disease specificity of Friend and Moloney murine leukemia viruses.
Chatis PA; Holland CA; Hartley JW; Rowe WP; Hopkins N
Proc Natl Acad Sci U S A; 1983 Jul; 80(14):4408-11. PubMed ID: 6308622
[TBL] [Abstract][Full Text] [Related]
20. Leukemogenicity of Moloney murine leukemia viruses carrying polyoma enhancer sequences in the long terminal repeat is dependent on the nature of the inserted polyoma sequences.
Fan H; Chute H; Chao E; Pattengale PK
Virology; 1988 Sep; 166(1):58-65. PubMed ID: 2842957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
